Quantitative HPLC-UV method for the determination of firocoxib from horse and dog plasma
Authors:
- Valerie KvaternickVKValerie Kvaternick
- Thomas MalinskiTMThomas Malinski
- Jill WortmannJWJill Wortmann
- James FischerJFJames Fischer
- 1 July 2007
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B
- Vol. 854 (1-2) , 313-319
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Pharmacokinetics and metabolism of orally administered firocoxib, a novel second generation coxib, in horsesJournal of Veterinary Pharmacology and Therapeutics, 2007
- An overview of the recent developments in analytical methodologies for determination of COX-2 inhibitors in bulk drugs, pharmaceuticals and biological matricesJournal of Pharmaceutical and Biomedical Analysis, 2005
- New insights into COX-2 biology and inhibitionBrain Research Reviews, 2005
- HPLC Determination and Pharmacokinetic Study of Valdecoxib in Human PlasmaChromatographia, 2005
- Development and validation of a reversed‐phase liquid chromatographic method for separation and simultaneous determination of COX‐2 inhibitors in pharmaceuticals and its application to biological fluidsBiomedical Chromatography, 2004
- Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and InhibitionPharmacological Reviews, 2004
- Liquid chromatography and chemometric methods for determination of rofecoxib in presence of its photodegradate and alkaline degradation productsAnalytica Chimica Acta, 2004
- The Second Generation of COX-2 InhibitorsDrugs, 2003
- Cyclooxygenase-2—10 Years LaterThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Mitogen‐inducible prostaglandin G/H synthase: A new target for nonsteroidal antiinflammatory drugsDrug Development Research, 1992